On October 5, 2025, new details emerged about a clinical trial exploring the relationship between muscle mechanics and key parameters in individuals with Multiple Sclerosis (MS). Sponsored by Sanko University, this study investigates the mechanical properties of respiratory and lower extremity muscles using advanced medical devices, including MyotonPRO. Currently enrolling participants by invitation, this trial aims to refine understanding of MS-related neuromuscular dynamics and potentially guide more precise interventions.
In this article:
- What changed?
- How will this study progress?
- How does MyotonPRO fit in?
- FAQ
- Conclusion
- Disclaimer
- Full study announcement
What changed?
This trial investigates the mechanical characteristics of respiratory and lower extremity muscles in MS patients, with a strong emphasis on correlating these parameters with other physiological findings obtained through breath tests and MyotonPRO technology. The new inclusion of advanced muscle assessment tools marks a significant evolution in studying neuromuscular disorders like MS, providing opportunities for innovation in diagnostic and therapeutic practices.
How will this study progress?
Enrolling by invitation
The trial adopts an invitation-only enrollment model, ensuring targeted participation by individuals meeting specific criteria. This approach is particularly valuable for gathering precise, consistent data that could lead to actionable insights.
Research goals
Sanko University aims to shed light on how MS affects muscle mechanics. Respiration and movement are central to this study, as both functions are critical in disease management. By focusing on these areas, researchers hope to uncover deeper connections between physical impairments and disease progression.
How does MyotonPRO fit in?
MyotonPRO is a medical device recognized for assessing muscle properties such as elasticity, stiffness, and tone. For MS, these features are essential indicators of disease impact and possible intervention points. By integrating this tool into the study, researchers aim to achieve unparalleled precision in neuromuscular assessments. This could later inform regulatory pathways for device use in similar contexts.
Benefits of using MyotonPRO
- Non-invasive measurement methods compatible with MS patients.
- High reproducibility and sensitivity to muscle property changes.
- Potential for broader application in neurology-based clinical trials.
FAQ
1. What is MyotonPRO?
MyotonPRO is a diagnostic medical device that measures mechanical properties of muscles, such as elasticity and stiffness.
2. Who is conducting the study?
The study is sponsored by Sanko University.
3. Can anyone enroll?
No, the study is enrolling by invitation only. Selected participants must meet specific eligibility criteria.
4. Why focus on respiratory and lower extremity muscles?
These muscle groups are particularly vulnerable in MS and influence patients’ quality of life significantly.
Conclusion
This clinical trial represents a unique opportunity to advance knowledge of MS by introducing innovative tools like MyotonPRO to study muscle function. For clinical, quality, and regulatory teams, monitoring this trial’s progress can help align international efforts in medical device applications and patient-centric approaches.
Disclaimer
This article is for informational purposes only. It is not intended as legal advice or as a substitute for professional regulatory consultation.
Full study announcement
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07202780?term=medical+device